https://www.selleckchem.com/pr....oducts/poziotinib-hm
Aim Sepsis is a significant cause of mortality and morbidity in the NICU despite the potent armamentarium of antibiotics. Recently, there has been a considerable increase in antimicrobial resistance even to high-end 3rd line antibiotics. Thus, there is a need to look into adjunctive therapies. This study aims to study the role of double volume exchange transfusion (DVET) in reducing mortality due to severe sepsis.Methods All neonates with severe sepsis admitted in NICU from January 2017 to September 2019 were included in th
Like
Comment
Share
